These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9258449)

  • 1. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation.
    Siemers NO; Kerr DE; Yarnold S; Stebbins MR; Vrudhula VM; Hellström I; Hellström KE; Senter PD
    Bioconjug Chem; 1997; 8(4):510-9. PubMed ID: 9258449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
    Svensson HP; Frank IS; Berry KK; Senter PD
    J Med Chem; 1998 Apr; 41(9):1507-12. PubMed ID: 9554883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering.
    McDonagh CF; Beam KS; Wu GJ; Chen JH; Chace DF; Senter PD; Francisco JA
    Bioconjug Chem; 2003; 14(5):860-9. PubMed ID: 13129388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and activities of a new melphalan prodrug designed for tumor-selective activation.
    Kerr DE; Li Z; Siemers NO; Senter PD; Vrudhula VM
    Bioconjug Chem; 1998; 9(2):255-9. PubMed ID: 9548542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of recombinant and synthetically formed monoclonal antibody-beta-lactamase conjugates for anticancer prodrug activation.
    Kerr DE; Vrudhula VM; Svensson HP; Siemers NO; Senter PD
    Bioconjug Chem; 1999; 10(6):1084-9. PubMed ID: 10563779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.
    Kerr DE; Schreiber GJ; Vrudhula VM; Svensson HP; Hellström I; Hellström KE; Senter PD
    Cancer Res; 1995 Aug; 55(16):3558-63. PubMed ID: 7627964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to beta-lactamase.
    Goshorn SC; Svensson HP; Kerr DE; Somerville JE; Senter PD; Fell HP
    Cancer Res; 1993 May; 53(9):2123-7. PubMed ID: 8481914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.
    Rodrigues ML; Presta LG; Kotts CE; Wirth C; Mordenti J; Osaka G; Wong WL; Nuijens A; Blackburn B; Carter P
    Cancer Res; 1995 Jan; 55(1):63-70. PubMed ID: 7805042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo activities of a doxorubicin prodrug in combination with monoclonal antibody beta-lactamase conjugates.
    Svensson HP; Vrudhula VM; Emswiler JE; MacMaster JF; Cosand WL; Senter PD; Wallace PM
    Cancer Res; 1995 Jun; 55(11):2357-65. PubMed ID: 7757987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction and expression of anti-human AFP ScFv gene in BL-21 (DE3) E. coli].
    Zhang P; Cai MY; Zhao ZR; Wei DP; Li G; Bi JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):20-3. PubMed ID: 15702771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical applications of single-chain antibodies.
    Huston JS; McCartney J; Tai MS; Mottola-Hartshorn C; Jin D; Warren F; Keck P; Oppermann H
    Int Rev Immunol; 1993; 10(2-3):195-217. PubMed ID: 8360586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cloning and expression of single chain Fv gene against human colorectal carcinoma].
    Fang J; Song JD
    Ai Zheng; 2002 Jul; 21(7):740-4. PubMed ID: 12479098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-selective prodrug activation by fusion protein-mediated catalysis.
    Bosslet K; Czech J; Hoffmann D
    Cancer Res; 1994 Apr; 54(8):2151-9. PubMed ID: 8174122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug.
    Mayer A; Francis RJ; Sharma SK; Tolner B; Springer CJ; Martin J; Boxer GM; Bell J; Green AJ; Hartley JA; Cruickshank C; Wren J; Chester KA; Begent RH
    Clin Cancer Res; 2006 Nov; 12(21):6509-16. PubMed ID: 17085666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and optimization of a CC49-based scFv-beta-lactamase fusion protein for ADEPT.
    Roberge M; Estabrook M; Basler J; Chin R; Gualfetti P; Liu A; Wong SB; Rashid MH; Graycar T; Babé L; Schellenberger V
    Protein Eng Des Sel; 2006 Apr; 19(4):141-5. PubMed ID: 16436454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.
    Vrudhula VM; Svensson HP; Kennedy KA; Senter PD; Wallace PM
    Bioconjug Chem; 1993; 4(5):334-40. PubMed ID: 8274516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
    Schultz J; Lin Y; Sanderson J; Zuo Y; Stone D; Mallett R; Wilbert S; Axworthy D
    Cancer Res; 2000 Dec; 60(23):6663-9. PubMed ID: 11118050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.